Medpace Holdings, Inc. (MEDP) Q4 FY25 Earnings Call

Strong growth and 2026 guidance are tempered by the highest backlog cancellations in over a year [5][16].

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-10
Length41 minutes
EPS$4.67
EPS consensus$4.18
Revenue$659.9M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26 · Q3 FY25 · Q2 FY25

All MEDP earnings · Back to MEDP overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.